|
Etoposide Impurity 15
|
依托泊苷雜質(zhì)15
|
|
|
Glimepiride Impurity 16
|
格列美脲雜質(zhì)16
|
|
|
Febuxostat Impurity 62
|
非布索坦雜質(zhì)62
|
|
|
Glimepiride Impurity 12
|
格列美脲雜質(zhì)12
|
|
|
Glimepiride Impurity 10
|
格列美脲雜質(zhì)10
|
|
|
Enzalutamide PO
|
恩雜魯胺PO
|
|
|
Enzalutamide Open - loop impurity
|
恩雜魯胺開(kāi)環(huán)雜質(zhì)
|
|
|
Etoposide Impurity 9
|
依托泊苷雜質(zhì)9
|
|
|
Etoposide Impurity 17
|
依托泊苷雜質(zhì)17
|
|
|
Etoposide Impurity 12
|
依托泊苷雜質(zhì)12
|
|
|
Clozapine N-oxide
|
|
34233-69-7
|
|
Dabigatran Impurity 20
|
達(dá)比加群酯雜質(zhì)20
|
|
|
Dabigatran Impurity 21
|
達(dá)比加群酯雜質(zhì)21
|
|
|
Dabigatran Etexilate iMpurity 23
|
達(dá)比加群酯雜質(zhì)23
|
|
|
Exemestane Impurity D
|
依西美坦雜質(zhì) D
|
|
|
Glyburide impurity B
|
格列本脲雜質(zhì) B
|
|
|
Lansoprazole IMpurity L
|
右旋蘭索拉唑雜質(zhì)L
|
|
|
Dabigatran Etexilate iMpurity 24
|
達(dá)比加群酯雜質(zhì)24
|
|
|
Dabigatran Impurity R
|
達(dá)比加群酯雜質(zhì)25
|
1643377-48-3
|
|
Dabigatran Impurity 27
|
達(dá)比加群酯雜質(zhì)27
|
1643392-59-9
|
|
Exemestane Impurity I
|
依西美坦雜質(zhì)I
|
|
|
Fludarabine EP impurity A
|
磷酸氟達(dá)拉濱EP雜質(zhì)A
|
|
|
Glimepiride Impurity 4
|
格列美脲雜質(zhì)4
|
|
|
Etoposide Impurity 6
|
依托泊苷雜質(zhì)6
|
|
|
Clindamycin phosphate Impurity K
|
克林霉素磷酸酯雜質(zhì)K
|
|
|
1,3-dimethyl-6,7,9,10-tetrahydro-7,10
|
多索茶堿雜質(zhì)B
|
|
|
Demiditraz Impurity 5
|
得米地曲雜質(zhì)5
|
944263-08-5
|
|
Exemestane Impurity E
|
依西美坦雜質(zhì)E
|
152764-24-4
|
|
Exemestane Impurity G
|
依西美坦雜質(zhì)G
|
152764-31-3
|
|
Fludarabine EP impurity J
|
氟達(dá)拉濱EP雜質(zhì)J
|
|
|
Dabigatran Impurity 35
|
達(dá)比加群酯雜質(zhì)35
|
58906-62-0
|
|
Duloxetine IMpurity 11
|
度洛西汀雜質(zhì)11
|
|
|
Fludarabine EP impurity F
|
氟達(dá)拉濱EP雜質(zhì)F
|
159002-28-5
|
|
Fludarabine EP impurity D
|
氟達(dá)拉濱EP雜質(zhì)D
|
700-49-2
|
|
Fasudil N-Hydroxy Impurity
|
法舒地爾N-羥基雜質(zhì)
|
1350827-92-7
|
|
Fasudil Dimer
|
法舒地爾二聚體
|
1337967-93-7
|
|
Dabigatran carbyne Impurity 28
|
達(dá)比加群酯雜質(zhì)28
|
66315-15-9
|
|
Dabigatran Impurity 19
|
達(dá)比加群酯雜質(zhì)19
|
1900865-84-0
|
|
Baricitinib Impurity I
|
度洛西汀雜質(zhì)D
|
90-15-3
|
|
(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)
|
度洛西汀雜質(zhì)9
|
878757-08-5
|
|
Duloxetine impurity G
|
度洛西汀雜質(zhì)G
|
321-38-0
|
|
Duloxetine EP impurity F
|
度洛西汀雜質(zhì)F
|
959392-22-4
|
|
(S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol
|
度洛西汀雜質(zhì)18
|
1384080-56-1
|
|
(R)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol
|
度洛西汀雜質(zhì)14
|
116539-57-2
|
|
Etoposide Impurity B
|
依托泊苷雜質(zhì)B
|
|
|
Etoposide Impurity 4
|
依托泊苷雜質(zhì)4
|
|
|
Etoposide Impurity 1
|
依托泊苷雜質(zhì)1
|
|
|
Etoposide Impurity D
|
依托泊苷雜質(zhì)D
|
|
|
Etoposide Impurity C
|
依托泊苷雜質(zhì) C
|
100007-53-2
|
|
Cycloserine Impurity 1
|
環(huán)絲氨酸雜質(zhì)1
|
339-72-0
|
|
Etoposide Impurity E
|
依托泊苷雜質(zhì)E
|
|
|
Etoposide Impurity 2
|
依托泊苷雜質(zhì)2
|
|
|
Clavulanic acid Impurity M
|
克拉維酸雜質(zhì)M
|
3033-62-3
|
|
Clavulanic acid Impurity L
|
克拉維酸雜質(zhì)L
|
4013-94-9
|
|
Doxofylline Impurity A
|
多索茶堿雜質(zhì)A
|
|
|
Fludarabine EP impurity C
|
氟達(dá)拉濱EP雜質(zhì)C
|
548774-53-4
|
|
Fludarabine EP impurity B
|
氟達(dá)拉濱EP雜質(zhì)B
|
149297-79-0
|
|
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)
|
氟達(dá)拉濱EP雜質(zhì)E
|
21679-14-1
|
|
Dabigatran Etexilate iMpurity 26
|
達(dá)比加群酯雜質(zhì)26
|
|
|
Lansoprazole IMpurity K
|
右旋蘭索拉唑雜質(zhì)K
|
|
|
Glimepiride Impurity 20
|
格列美脲雜質(zhì)20
|
|
|
Glimepiride Impurity 15
|
格列美脲雜質(zhì)15
|
|
|
Glimepiride Impurity 2
|
格列美脲雜質(zhì)2
|
|
|
Etoposide Impurity 11
|
依托泊苷雜質(zhì)11
|
|
|
Etoposide Impurity 18
|
依托泊苷雜質(zhì)18
|
|
|
Etoposide Impurity 19
|
依托泊苷雜質(zhì)19
|
|
|
Etoposide Impurity 13
|
依托泊苷雜質(zhì)13
|
|
|
Etoposide Hydroxy isomer
|
依托泊苷羥基異構(gòu)體
|
|
|
Etoposide Impurity 10
|
依托泊苷雜質(zhì)10
|
|
|
Glimepiride Impurity 18
|
格列美脲雜質(zhì)18
|
|
|
Fludarabine Isome L
|
氟達(dá)拉濱異構(gòu)體L
|
|
|
Dextrorotation lansoprazole Impurity 11
|
右旋蘭索拉唑雜質(zhì)11
|
|
|
Exemestane Impurity H
|
依西美坦雜質(zhì)H
|
|
|
Exemestane Impurity J
|
依西美坦雜質(zhì)J
|
|
|
Etoposide Impurity 7
|
依托泊苷雜質(zhì)7
|
|
|
Etoposide Impurity 8
|
依托泊苷雜質(zhì)8
|
|
|
Etoposide Impurity 14
|
依托泊苷雜質(zhì)14
|
|
|
Glimepiride Impurity 13
|
格列美脲雜質(zhì)13
|
|
|
1-methyl-12-thioxobenzo[4',5']imidazo
|
右旋蘭索拉唑雜質(zhì)H
|
|
|
Duloxetine IMpurity 19
|
度洛西汀雜質(zhì)19
|
1384080-33-4
|
|
Etoposide Impurity 3
|
依托泊苷雜質(zhì)3
|
|
|
116539-60-7;(R)-N-methyl-3-(naphthalen-1-yloxy)
|
度洛西汀雜質(zhì)A
|
910138-96-4
|
|
((2R,3S,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)
|
氟達(dá)拉濱EP雜質(zhì)K
|
|
|
Dextrorotation lansoprazole-N-oxide
|
右旋蘭索拉唑-N-氧化物雜質(zhì)
|
|
|
Fludarabine EP impurity I
|
氟達(dá)拉濱EP雜質(zhì)I
|
7561-54-8
|
|
Glimepiride Impurity 3
|
格列美脲雜質(zhì)3
|
|
|
Etoposide Impurity S
|
依托泊苷雜質(zhì)S
|
|
|
Glimepiride Impurity 1
|
格列美脲雜質(zhì)1
|
|
|
Glyburide impurity A
|
格列本脲雜質(zhì) A
|
|
|
Lansoprazole IMpurity M
|
右旋蘭索拉唑雜質(zhì)M
|
|
|
Lansoprazole IMpurity I
|
右旋蘭索拉唑雜質(zhì)I
|
|
|
Lansoprazole IMpurity J
|
右旋蘭索拉唑雜質(zhì)J
|
|
|
Glimepiride Impurity 19
|
格列美脲雜質(zhì)19
|
|
|
Glimepiride Impurity 17
|
格列美脲雜質(zhì)17
|
|
|
Etoposide Impurity 16
|
依托泊苷雜質(zhì)16
|
|
|
Glimepiride Impurity 14
|
格列美脲雜質(zhì)14
|
|
|
Dexmedetomidine Impurity A
|
右美托咪定雜質(zhì)A
|
|
|
Glimepiride Impurity 11
|
格列美脲雜質(zhì)11
|
|
|
Etoposide Impurity 5
|
依托泊苷雜質(zhì)5
|
|
|
Etoposide Impurity Z
|
依托泊苷雜質(zhì)Z
|
|